Integrated Microfluidic LC-MS - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Integrated Microfluidic LC-MS
The authors describe a new microfluidic-based workflow that integrates and automates glycan cleaveage, purification, and chromatographic separation onto a microfluidic liquid chromatography–mass spectrometry chip for MS detection.


Pharmaceutical Technology
Volume 34, pp. s32-s39

Traditional N-glycan characterization methods

Various methods are used to characterize N-glycans. Figure 1 summarizes those most commonly used. Most require multiple steps and a day or more to complete. All typically follow the same basic process as follows:

  • Release of glycans from glycoproteins
  • Separation of glycans from the deglycosylated protein
  • Analysis (separation, detection, identification, and quantification) of glycans with or without derivatization.

Enzymatic digestion with PNGase F ((peptide-N4-(N-acetyl-β-D-glucosaminy-I)) asparagine amidase F; EC 3.5.1.52) is commonly used to release glycans from glycoproteins. PNGase F is an amidase that cleaves the amide bond between the glycosylation-site asparagine and the innermost N-acetyl-β-D-glucosamine residue of N-glycans. It has a wide specificity, releasing all major classes of N-glycans found on mammalian glycoproteins. As shown in Figure 1, this method of deglycosylation involves long incubation times of 3 to 20 h, a significant component of the overall analysis time.

After releasing the glycans, the next step is to separate and recover them from the deglycosylated protein. This step is commonly done using reverse-phase or graphitized carbon-based solid-phase extraction, ultrafiltration, and precipitation. Centrifugal evaporation is typically needed to concentrate and dry the purified glycans. Depending on the method used, this step can take several hours to complete (see Figure 1).

Various methods are used to separate and detect glycans. Although high pH anion-exchange chromatography (HPAEC), with pulsed amperometric detection (PAD), has been popular because it does not require derivatization (4), it is being replaced by newer methods such as high-performance liquid chromatography (HPLC) and capillary electrophoresis (CE) with fluorescence detection. To improve the separation and enhance detection sensitivity, these methods involve derivatizing free glycans with fluorophore (via reductive amination.) After separation, the glycans' retention time or migration time is measured, and peaks are correlated with standards. Relative quantitation is performed based on the fluorescence of individual peaks (5). For CE analysis, glycans are usually labeled with fluorescent tag APTS (8-aminopyrene-1,3,6-trisulfonic acid.) (6). For HPLC analysis, glycans are typically labeled with a fluorescent label such as 2-aminopyridine (2-AP), anthranilic acid (2-AA), or 2-aminobenzamide (2-AB), and separation is performed using either hydrophilic interaction chromatography (HILIC) or reverse-phase chromatography. Depending on the method used, labeling requires about 1–3 h to complete. Postlabeling cleanup further increases the time requirements needed to complete the analysis.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
42%
Facility/environment problems
0%
Process development problems
8%
Production equipment downtime
8%
Raw material supply problems
25%
Regulatory restrictions
0%
Business decisions to limit production
17%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Patent Settlements Become More Risky
Praise and Perils for Biotechnology Patent Policy
Risk-Mitigation Strategies in Drug Manufacturing for Emerging Markets
Quality Focus: Ensuring Raw Material Transparency
Advertising of Prescription Drugs  Keeping it Honest and Balanced
Source: Pharmaceutical Technology,
Click here